Hedley Mary Lynne — SEC Form 4 filings
SEC reporting owner CIK 1340823. 41 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2024-01-17 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 58.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ELI LILLY & Co (LLY) | Director | 24 | — | — | 26 |
| VEEVA SYSTEMS INC (VEEV) | Director | 14 | — | — | 25 |
| Centessa Pharmaceuticals plc (CNTA) | Director | 3 | — | — | 7 |
Form 4 filings — Hedley Mary Lynne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 477 @ $0 · Option exercise (M): 477 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Centessa Pharmaceuticals plc (CNTA) | Disposition to issuer (D): 208,474 (derivative) · Disposition to issuer (D): 48,000 (derivative) · Disposition to issuer (D): 48,000 (derivative) · Disposition to issuer (D): 48,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) | EDGAR |
| 2026-06-22 | 4 | VEEVA SYSTEMS INC (VEEV) | Grant/award (A): 1,906 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 262 @ $0 · Option exercise (M): 262 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 262 @ $0 · Option exercise (M): 262 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 9.34 @ $1,062.19 | EDGAR |
| 2025-12-02 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 263 @ $0 · Option exercise (M): 263 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 9.71 @ $1,021.70 · Grant/award (A): 215.33 @ $1,021.70 | EDGAR |
| 2025-10-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 12.26 @ $808.96 | EDGAR |
| 2025-09-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13.25 @ $748.19 | EDGAR |
| 2025-09-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 262 @ $0 · Option exercise (M): 262 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 14.21 @ $698.05 | EDGAR |
| 2025-07-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13.01 @ $762.18 | EDGAR |
| 2025-06-24 | 4 | Centessa Pharmaceuticals plc (CNTA) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | VEEVA SYSTEMS INC (VEEV) | Grant/award (A): 1,049 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 12.28 @ $807.58 | EDGAR |
| 2025-06-02 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 343 @ $0 · Option exercise (M): 343 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13.13 @ $755.11 | EDGAR |
| 2025-04-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 12.12 @ $818.02 | EDGAR |
| 2025-03-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 12.02 @ $824.76 | EDGAR |
| 2025-03-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 342 @ $0 · Option exercise (M): 342 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11.57 @ $857.20 | EDGAR |
| 2025-01-23 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13.36 @ $742.35 | EDGAR |
| 2024-12-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 12.73 @ $779 | EDGAR |
| 2024-12-02 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 343 @ $0 · Option exercise (M): 343 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13.64 @ $727.20 · Grant/award (A): 302.53 @ $727.20 | EDGAR |
| 2024-10-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $906.13 | EDGAR |
| 2024-09-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $923.54 | EDGAR |
| 2024-09-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 343 @ $0 · Option exercise (M): 343 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $921.81 | EDGAR |
| 2024-07-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 10 @ $950.46 | EDGAR |
| 2024-06-27 | 4 | Centessa Pharmaceuticals plc (CNTA) | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | VEEVA SYSTEMS INC (VEEV) | Grant/award (A): 1,371 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $885.01 | EDGAR |
| 2024-06-03 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 302 @ $0 · Option exercise (M): 302 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $783.18 | EDGAR |
| 2024-04-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $750.77 | EDGAR |
| 2024-03-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $762.66 | EDGAR |
| 2024-03-05 | 4 | VEEVA SYSTEMS INC (VEEV) | Option exercise (M): 302 @ $0 · Option exercise (M): 302 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $755.66 | EDGAR |
| 2024-01-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 16 @ $634.57 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1340823 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →